Supplementary Material – PD-1 Targeted Immunotherapy For Advanced Hepatocellular Cancer: Current Utilization And Outcomes In The United States

NIAID Data Ecosystem2026-03-13 收录

下载链接：

https://figshare.com/articles/dataset/Supplementary_Material_PD-1_Targeted_Immunotherapy_For_Advanced_Hepatocellular_Cancer_Current_Utilization_And_Outcomes_In_The_United_States/19187984

下载链接

链接失效反馈

官方服务：

资源简介：

Supplementary Material. PD-1 Targeted Immunotherapy For Advanced Hepatocellular Cancer: Current Utilization And Outcomes In The United States Supplemental Table 1: ICD 09 and ICD 10 codes used for abstraction of patient comorbidities. Supplemental Table 2: comorbidities of included patients. Supplemental Figure 1: proportion of advanced HCC receiving PD-1 IMT according to US geography. Supplemental Figure 2: interaction analyses showing treatment effectiveness of PD-1 IMT versus no PD-1 IMT across patient subgroups. P-values were adjusted for multiplicity using the Bonferroni correction.

创建时间：

2022-02-17